Loading clinical trials...
Loading clinical trials...
A Phase II Study Of Perifosine (D-21266) In Patients With Previously Untreated Metastatic Or Locally Advanced Soft Tissue Sarcoma
Conditions
Interventions
perifosine
Locations
6
Canada
Tom Baker Cancer Center - Calgary
Calgary, Alberta, Canada
British Columbia Cancer Agency - Vancouver Island Cancer Centre
Vancouver, British Columbia, Canada
Margaret and Charles Juravinski Cancer Centre
Hamilton, Ontario, Canada
Cancer Care Ontario-London Regional Cancer Centre
London, Ontario, Canada
Mount Sinai Hospital - Toronto
Toronto, Ontario, Canada
Maisonneuve-Rosemont Hospital
Montreal, Quebec, Canada
Start Date
June 9, 2003
Primary Completion Date
September 18, 2004
Completion Date
September 22, 2008
Last Updated
August 4, 2023
NCT05039801
NCT06066138
NCT04704661
NCT05489211
NCT07479732
NCT03715933
Lead Sponsor
NCIC Clinical Trials Group
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions